Covance is one of the world’s largest and most comprehensive drug development services companies with more than 12,000 employees in 60 countries. Through its lead optimization, nonclinical, clinical and commercialization services, Covance has helped pharmaceutical and biotech companies develop one-third of all prescription medicines in the market today.
More than 250 talented and innovative leaders, representing every discipline in the healthcare industry, recently convened in New York for the Forbes Healthcare Summit to identify workable solutions to an increasing untenable model. A day of discussions and debates on everything from insurance plans and the walk-in clinic revolution to big data and personalized medicine revealed one overarching theme: pharma has to do more and it has to do it faster.
Covance Chairman and CEO Joe Herring spoke on how contract research organizations (CROs) can help get new medicines to market faster. With the talent and technology in place and a single-minded focus on drug development, Covance is helping pharma and biotech clients do things faster, cheaper, and smarter. Click here to view Joe Herring’s interview with Matt Herper, Forbes’ Senior Editor.